Shailesh Kumar PatelG. SaikumarJigyasa RanaJaideep DhamaMohd. Iqbal YatooRuchi TiwariAlfonso J. Rodríguez‐MoralesKuldeep Dhama2026-03-222026-03-22202010.1016/j.tmaid.2020.101844https://doi.org/10.1016/j.tmaid.2020.101844https://andeanlibrary.org/handle/123456789/43711Citaciones: 44enCritically illCoronavirus disease 2019 (COVID-19)DexamethasoneMedicine2019-20 coronavirus outbreakIntensive care medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MEDLINEVirologyDexamethasone: A boon for critically ill COVID-19 patients?article